Stetz Gary S. II

SEC Form 4 insider trading activity

Stetz Gary S. II has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.

On the most recent filing, Stetz Gary S. II is listed as Director at Hepion Pharmaceuticals, Inc. Inside the rolling window, Stetz Gary S. II reported 1 open-market purchase totaling $25K in HEPA and no open-market sales.

Companies traded

Other insiders at HEPA

Insider Buying

$25K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
HEPA
Stetz Gary S. II
Purchase$25KAug 13SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Stetz Gary S. II made?

Stetz Gary S. II has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Stetz Gary S. II trade?

Stetz Gary S. II has filed SEC Form 4 disclosures for 1 company, including HEPA.

When was Stetz Gary S. II's most recent SEC Form 4 filing?

Stetz Gary S. II's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.

What is Stetz Gary S. II's total buy and sell value in the current window?

Inside the rolling retention window, Stetz Gary S. II bought $25K and sold $0 based on SEC Form 4 filings.

What was Stetz Gary S. II's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 500,000 HEPA shares on 2026-08-03, worth $25K, per SEC Form 4 filings.